ONCADERM – Excellence in Education

The Centre for Translational Skin Research & the Department of Dermatology at Westmead Hospital are pleased to announce the ONCADERM educational program has won the 2018 PRIME “Excellence in Education” award.
The ONCADERM program is a project developed by our oncodermatology experts, oncology nurses from around Australia, and Vivacity Health sponsored by Merck.
The main focus of this initiative was to train Oncology nurses in the recognition, prevention and treatment of the muco-cutaneous adverse effects associated with Epidermal Growth Factor Inhibitor therapy.
It’s been now presented in conferences and in a number of hospitals nationwide with a valuable impact in patient’s care and quality of life.
Prof Pablo Fernández-Peñas and Dr Germana Consuegra had fundamental roles in the ONCADERM program leading the discussion of current treatment guidelines and evidence-based management as well as supplying expert advise in the implementation of those during everyday clinical practice.
The learning outcomes of the program are:
– Recount how the mechanism of action of the epidermal growth factor receptor (EGFR) inhibitor affects the structure and function of skin
– Be able to recognise and describe cutaneous reactions associated with EGFR inhibitor (EGFRi) treatment
– Follow general management pathways for EGFRi-associated cutaneous reactions
– Develop an active involvement in preventing, assessing and managing cutaneous reactions associated with EGFRi
– Complete consultation templates for patients documenting the cutaneous reaction, if present, preventive strategies for all skin and management strategies for areas affected by cutaneous reactions, when to come back for review and clear instructions on when to seek urgent medical review